Inflection Biosciences

Inflection Biosciences Ltd is an early stage, drug development company with a focus on discovering and developing innovative small molecule therapeutics addressing major unmet needs in cancer.

Industries

Headquarters

Blackrock, Ireland

Stage

Seed

Employees

1-10

Links

Org chart

Darren Cunningham
CEO and Co-Founder
Collapse
Shaun McNulty
Chief Scientific Officer
Tess Barker
Head of Development
Kathy Gately
Senior Scientist (Translational Oncology)
Paul Dickinson
CMC: Preclinical and Clinical Formulation Development
David Lathbury
CMC: Process Chemistry
Frank Bonner
Head of Non-Clinical Safety
Gerry McGettigan
Regulatory Affairs
Gemma Carroll
Financial Controller
Two candidates
The Org
helps you hire
great candidates
It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.